Back to Results
First PageMeta Content
Myelofibrosis / Janus kinase inhibitor / Essential thrombocytosis / Thrombocytosis / Splenomegaly / Polycythemia vera / Myeloproliferative disease / Thrombocytopenia / TG101348 / Medicine / Hematopathology / Ruxolitinib


Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca
Add to Reading List

Document Date: 2015-05-13 10:22:06

Open Document

File Size: 177,73 KB

Share Result on Facebook

City

San Francisco / Stockholm / New Orleans / Basel / Dorval / /

Company

AEs / Media Relations Andrea Gilpin Novartis Pharmaceuticals Canada Inc. / Novartis Group / Novartis Pharmaceuticals Canada Inc. / Novartis AG / Canadian MPN Group / /

Country

Switzerland / Sweden / Canada / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Princess Margaret Cancer Centre / /

IndustryTerm

over-the-counter and animal health products / generic pharmaceuticals / healthcare field / healthcare solutions / /

MedicalCondition

headache / herpes zoster / enrolled myelofibrosis / Hematological Malignancies / thrombocytopenia / primary myelofibrosis / Idiopathic myelofibrosis / fatigue / Canadian Myeloproliferative Neoplasms / blood cancer / urinary tract infections / infections / myelofibrosis / chronic idiopathic myelofibrosis / disease / neutropenia / postpolycythemia vera myelofibrosis / fever / About Myelofibrosis Myelofibrosis / dizziness / uncommon blood cancer / anemia / hypercholesterolemia / tuberculosis / /

Organization

Leukemia & Lymphoma Society / US Securities and Exchange Commission / Princess Margaret Cancer Centre in Toronto / Congress / American Society of Hematology / European Hematology Association / /

Person

Tony Comper / Vikas Gupta / Cheryl Petruk / /

/

Position

President / leader / Chairperson / /

Product

fluconazole / Canada / /

ProvinceOrState

Quebec / California / /

Technology

transplantation / pdf / /

URL

http /

SocialTag